NCT07378241

Brief Summary

Investigastors hypothesis is that the need for anaesthetic agents is less in patients with high progesterone levels and more in patients with high estrogen levels.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2025

Completed
8 months until next milestone

First Posted

Study publicly available on registry

January 30, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

January 30, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

January 30, 2026

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

May 26, 2025

Last Update Submit

January 28, 2026

Conditions

Keywords

sedoanalgesiaOPUProgesteroneestrogen

Outcome Measures

Primary Outcomes (1)

  • Anesthetic consumptiom

    the amount of propofol needed to provide adequate depth of anaesthesia in mg/kg/minute

    intraoperative

Secondary Outcomes (3)

  • Pulse oximeter

    intraoperative

  • hearth rate changes

    intraoperative

  • Blood pressure changes

    intraoperative

Study Arms (1)

OPU patients

patients progesteron estrogen levels and progesteron/estrogen ratios

Drug: Anesthesia Maintenance

Interventions

the amount of propofol required to achieve depth of anaesthesia in mg/kg/minute

OPU patients

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Between 18-45 years old * ASA-I ASA-II patients who were sedated for oocyte pick-up between 1 June 2025 and 1 September 2025 at Izmir City Hospital * Patients whose hormone levels were measured in the preoperative period due to surgical indication and registered in the hospital data processing system

You may qualify if:

  • Between 18-45 years old
  • ASA-I ASA-II patients who were sedated for oocyte pick-up between 1 June 2025 and 1 September 2025 at Izmir City Hospital
  • Patients whose hormone levels were measured in the preoperative period due to surgical indication and registered in the hospital data processing system

You may not qualify if:

  • Lack of patient approvel
  • Diagnosed psychiatric disorder
  • Use of drugs affecting the central nervous system
  • Presence of chronic pain syndrome
  • History of continuous analgesic use due to chronic pain
  • Hepatic and/or renal insufficiency
  • BMI\>30
  • Changing the method of anaesthesia for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lee J, Lee J, Ko S. The relationship between serum progesterone concentration and anesthetic and analgesic requirements: a prospective observational study of parturients undergoing cesarean delivery. Anesth Analg. 2014 Oct;119(4):901-905. doi: 10.1213/ANE.0000000000000366.

Study Officials

  • Halide Hande Şahinkaya, MD

    Izmir City Hospital, Anesthesiology and Reanimation Department

    STUDY CHAIR
  • Tuba Kuvvet Yoldaş, MD

    Izmir City Hospital, Anesthesiology and Reanimation Department

    STUDY CHAIR
  • Zeki Tuncer Tekgul, Prof. Dr.

    Izmir City Hospital, Anesthesiology and Reanimation Department

    STUDY CHAIR

Central Study Contacts

GOZDE GURSOY CIRKINOGLU, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 26, 2025

First Posted

January 30, 2026

Study Start

January 30, 2026

Primary Completion

March 1, 2026

Study Completion

April 30, 2026

Last Updated

January 30, 2026

Record last verified: 2025-12